RMD ResMed spikes on robust results and global growth spurt ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results. Keely Lynch 3 days ago ASX News Healthcare Medical Devices
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial Recce Pharma will dose patients with 4g of its R327 intravenous solution to treat UTIs in Phase I/II trials following safety board approval. Jonathon Davidson 3 days ago ASX News Healthcare
EMD Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair has funded the company $0.3M on Tuesday. Jonathon Davidson 6 days ago ASX News Healthcare
PAA PharmAust CEO's sayanora triggers stock plunge Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn. Keely Lynch 6 days ago ASX News Healthcare
GSS Genetic Signatures wins TGA greenlight for flu test device – just before winter Genetic Signatures (ASX:GSS) shares were down -1.45% to 68cps on Monday, even as the company reported a greenlight from the TGA. Jonathon Davidson 7 days ago ASX News Healthcare Technology Scientific & Technical Instruments
PYC PYC Therapeutics takes Polycystic Kidney Disease drug to human trials PYC Therapeutics takes its latest drug for Polycystic Kidney Disease, characterized by the formation of cysts in the kidneys to human trials. Fouad Haidar 7 days ago ASX News Healthcare Biotechnology
RCE Recce weighs in on Q1 2024 as cash increases 100% Recce Pharmaceuticals, developing a new body of anti-infectives for global markets, weighs in on the last three months. Jonathon Davidson 7 days ago ASX News Healthcare
IIQ Sayona sells $13.7M Troilus stake to grow lithium plays as prices low Hotly watched ASX stock Sayona Mining has sold $12M worth of shares of Toronto-listed Troilus Gold Corp to advance two key lithium assets. Jonathon Davidson 19 Apr 2024 12:45 (AEST) ASX News Healthcare Steel Basic Materials
IIQ Inoviq closes the gap on blood test results for ovarian cancer INOVIQ has announced encouraging blood test identification results for ovarian cancer – cancer-positive tests saw a 76% success rate. Dale Granger 19 Apr 2024 10:30 (AEST) ASX News Healthcare
PAR Paradigm Biopharma on track to US Phase III osteo program Paradigm Biopharma has announced its completion of a submission to the US FDA to progress to Phase III of its osteoarthritis 'program.' Jonathon Davidson 19 Apr 2024 10:14 (AEST) ASX News Healthcare Biotechnology
A good trip? Psychedelics and the future of mental health There's an emerging body of research suggesting the true value of psychedelics might be found in treating psychiatric conditions such as post-traumatic stress disorder (PTSD) and persistent depression. Caroline Smith 18 Apr 2024 15:48 (AEST) ASX News Special Report The Expert Exchange Healthcare
FRE Firebrick Pharma's US launch of Nasal Spray is nothing to be sneezed at Australian pharmaceutical developer, Firebrick Pharma (ASX:FRE) has launched its latest product, Nasodine Nasal Spray, in the US market. Keely Lynch 17 Apr 2024 14:40 (AEST) ASX News Healthcare
LGP Little Green Pharma heading into Q2 cashed up after record sales Little Green Pharma (ASX:LGP) wound up Q1CY24 with $5M in cash after posting record sales of $8.1M, up 53% QoQ. Jonathon Davidson 17 Apr 2024 11:57 (AEST) ASX News Healthcare